Loading…
Development of the opioid self-management scale for advanced Cancer patients with pain and examination of its validity and reliability
Approximately 60% of outpatients with advanced cancer experience pain; therefore, self-management of opioid use is important for appropriate pain relief. To date, no studies have clearly described the concept of opioid self-management or assessed the factors involved, including the improvement of se...
Saved in:
Published in: | BMC palliative care 2022-06, Vol.21 (1), p.102-102, Article 102 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Approximately 60% of outpatients with advanced cancer experience pain; therefore, self-management of opioid use is important for appropriate pain relief. To date, no studies have clearly described the concept of opioid self-management or assessed the factors involved, including the improvement of self-management abilities. This study developed, and evaluated the validity and reliability of an opioid self-management scale for advanced cancer patients with pain (OSSA). Opioid self-management in advanced cancer patients with pain was defined as the management of opioid medication performed by patients with advanced cancer to relieve cancer pain on their own.
Three phases were required for validation and reliability of the OSSA: 1) testing content validity, 2) testing face validity, and 3) testing construct validity, concurrent validity and reliability.
After a three-phase process, the OSSA consisted of 33 items on six subscales. The structural equation modeling was such that the χ
value was 709.8 (p |
---|---|
ISSN: | 1472-684X 1472-684X |
DOI: | 10.1186/s12904-022-00987-4 |